A patient on semaglutide had residual stomach contents despite standard fasting and withholding one dose, leading to procedure cancellation — but had no such issue on a prior occasion.
Unpredictable gastroparesisSame patient, same preparation — different gastric emptying outcomes on two occasions
What the researchers found
Standard fasting guidelines plus withholding one semaglutide dose may not reliably ensure gastric emptying before endoscopy, with effects varying even in the same patient.
Why it matters
Millions of GLP-1 RA users will need sedated procedures. Inconsistent gastric emptying poses aspiration risk and creates anesthesia management challenges.
How the study worked
Case report comparing two endoscopy experiences in the same patient on semaglutide with identical preparation protocols.
What this study cannot tell us
Single case with inconsistent findings — the variable outcome makes it harder to draw conclusions than a consistent finding would.
How to read the evidence
Case report — illustrates a clinical challenge but cannot establish reliable risk estimates or optimal management strategies.
When this study was published
Published 2026 in A&A Practice.
The bigger picture
Current pre-procedure fasting guidelines may be inadequate for GLP-1 RA users. Standardized peri-procedural protocols for this growing patient population are urgently needed.
Questions still open
- Should GLP-1 RA users have longer fasting periods or additional gastric emptying assessments before sedated procedures?
- How many doses should be withheld to ensure adequate gastric emptying?
Common questions
Does semaglutide affect stomach emptying before procedures?
How many doses of semaglutide should you skip before a procedure?
Read the original research
Unexpected Residual Gastric Contents in a Patient After Holding Semaglutide After Standard Fasting Guidelines: A Case Report.
A&A practice, 20(2), e02161
Citation
Ando, Kazuo; Takenoshita, Moe; Wei, Mike Tzuhen. (2026). Unexpected Residual Gastric Contents in a Patient After Holding Semaglutide After Standard Fasting Guidelines: A Case Report.. A&A practice, 20(2), e02161. https://doi.org/10.1213/XAA.0000000000002161